Press Release Archives Year: 2024

SSG Advises Eiger BioPharmaceuticals, Inc. in the Sale of Avexitide Program Assets to Amylyx Pharmaceuticals

SSG Advises CPL in the Sale to Aterian Investment Partners

SSG Advises Eiger BioPharmaceuticals, Inc. in the Sale of Zokinvy® Program Assets to Sentynl Therapeutics, Inc.

SSG Advises the Chapter 7 Trustee of ContraFect Corporation in the Sale of Substantially All Intellectual Property Assets to Aurobac Therapeutics SAS

Teresa C. Kohl Recognized with the M&A Advisor’s 2024 Leadership Award

SSG Advises St. Cloud Capital LLC in the Sale of Renters Warehouse to GA Technologies

SSG Advises Christmas by Krebs Corporation in the Sale of Substantially all of its Assets to The Gerson Companies

SSG Advises Infinity Pharmaceuticals, Inc. in the Sale of Substantially all of its Assets to a Healthcare Investment Firm

SSG Capital Advisor’s 2023 Year in Review